Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Neena Goyal. (2013) Novel approaches for the identification of inhibitors of leishmanial dipeptidylcarboxypeptidase. Expert Opinion on Drug Discovery 8:9, pages 1127-1134.
Read now
Read now
Guilherme Carneiro, Marta Gontijo Aguiar, Ana Paula Fernandes & Lucas Antônio Miranda Ferreira. (2012)
Drug delivery systems for the topical treatment of cutaneous leishmaniasis
. Expert Opinion on Drug Delivery 9:9, pages 1083-1097.
Read now
Read now
Sunandini Chandra, Dipali Ruhela, Anindita Deb & Ram A Vishwakarma. (2010) Glycobiology of the Leishmania parasite and emerging targets for antileishmanial drug discovery. Expert Opinion on Therapeutic Targets 14:7, pages 739-757.
Read now
Read now
Margriet den Boer & Robert N Davidson. (2006) Treatment options for visceral leishmaniasis. Expert Review of Anti-infective Therapy 4:2, pages 187-197.
Read now
Read now
Articles from other publishers (39)
Ermin Schadich, Susanne Nylén, Soňa Gurská, Jana Kotulová, Sergey Andronati, Victor Pavlovsky, Svetlana Soboleva, Pavel Polishchuk, Marián Hajdúch & Petr Džubák. (2022) Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana. Parasitology International 91, pages 102647.
Crossref
Crossref
Regina Maia de Souza, Roberta Cristina Ruedas Martins, Lucas Augusto Moyses Franco, Felipe Francisco Tuon, Isael Gomes de Oliveira Junior, Camila Alves Maia da Silva, Rui Imamura & Valdir Sabbaga Amato. (2022) Identification of Leishmania species by next generation sequencing of hsp70 gene. Molecular and Cellular Probes 61, pages 101791.
Crossref
Crossref
Viviane Pereira, Neuza Biguinati de Barros, Sharon Rose Aragão Macedo, Amália dos Santos Ferreira, Luiz Alberto Kanis & Roberto Nicolete. (2019) Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis. Journal of Parasitic Diseases 44:1, pages 79-87.
Crossref
Crossref
Luiz C. S. Pinheiro, Maria de Lourdes G. Ferreira, Flávia F. Silveira, Lívia M. Feitosa & Nubia Boechat. (2019) Synthetic compounds with sulfonamide moiety against Leishmaniasis: an overview. Medicinal Chemistry Research 28:11, pages 1807-1817.
Crossref
Crossref
Elias Ferreira Sabiá Júnior, Luis Felipe Santos Menezes, Israel Flor Silva de Araújo & Elisabeth Ferroni Schwartz. (2019) Natural Occurrence in Venomous Arthropods of Antimicrobial Peptides Active against Protozoan Parasites. Toxins 11:10, pages 563.
Crossref
Crossref
Eliane de Morais-Teixeira, Ana Rabello & Marta Marques Gontijo Aguiar. (2019) In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species. Journal of Antimicrobial Chemotherapy 74:8, pages 2318-2325.
Crossref
Crossref
Emilia Díaz & Alicia Ponte-Sucre. 2018. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
1
16
.
Robert O. Greer, Robert E. Marx, Sherif Said & Lori D. ProkSherif Said & Robert O. Greer. 2017. Pediatric Head and Neck Pathology. Pediatric Head and Neck Pathology
310
329
.
Rafik Ben Rhaiem & Mehdi Houimel. (2016) Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library. Acta Tropica 159, pages 11-19.
Crossref
Crossref
Eliane de Morais-Teixeira, Marta Gontijo Aguiar, Bruna Soares de Souza Lima, Lucas Antônio Miranda Ferreira & Ana Rabello. (2015)
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by
Leishmania
(
Viannia
)
braziliensis
. Journal of Antimicrobial Chemotherapy, pages dkv254.
Crossref
Crossref
Behrouz Ezatpour, Ebrahim Saedi Dezaki, Hossein Mahmoudvand, Mojgan Azadpour & Fatemeh Ezzatkhah. (2015)
In Vitro
and
In Vivo
Antileishmanial Effects of
Pistacia khinjuk against Leishmania tropica
and
Leishmania major
. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-6.
Crossref
Crossref
Denis Zofou, Raymond B Nyasa, Dickson S Nsagha, Fidele Ntie-Kang, Henry D Meriki, Jules Clement N Assob & Victor Kuete. (2014) Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements. Infectious Diseases of Poverty 3:1.
Crossref
Crossref
Ifedayo Victor Ogungbe, Joseph D Ng & William N Setzer. (2013)
Interactions of antiparasitic alkaloids with
Leishmania
protein targets: a molecular docking analysis
. Future Medicinal Chemistry 5:15, pages 1777-1799.
Crossref
Crossref
Christopher F. Prada, Raquel ?lvarez-Velilla, Rafael Bala?a-Fouce, Carlos Prieto, Estefania Calvo-?lvarez, Jose Miguel Escudero-Mart?nez, Jos? Mar?a Requena, C?sar Ord??ez, Alessandro Desideri, Yolanda P?rez-Pertejo & Rosa M. Reguera. (2013) Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect. Biochemical Pharmacology 85:10, pages 1433-1440.
Crossref
Crossref
A. Ponte-Sucre. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
1
12
.
Bhaskar, Neeti Kumari & Neena Goyal. (2012) Cloning, characterization and sub-cellular localization of gamma subunit of T-complex protein-1 (chaperonin) from Leishmania donovani. Biochemical and Biophysical Research Communications 429:1-2, pages 70-74.
Crossref
Crossref
Christopher F. Prada, Raquel Álvarez-Velilla, Rosario Diaz-González, Carlos Prieto, Yolanda Pérez-Pertejo, Rafael Balaña-Fouce & Rosa M. Reguera. (2012) A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:12, pages 2062-2071.
Crossref
Crossref
Diogo G. Valadares, Mariana C. Duarte, Laura Ramírez, Miguel A. Chávez-Fumagalli, Vivian T. Martins, Lourena E. Costa, Paula S. Lage, Tatiana G. Ribeiro, Rachel O. Castilho, Ana Paula Fernandes, Wiliam C.B. Régis, Manuel Soto, Carlos A.P. Tavares & Eduardo A.F. Coelho. (2012) Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis. Experimental Parasitology 132:2, pages 228-236.
Crossref
Crossref
Diogo G. Valadares, Mariana C. Duarte, Laura Ramírez, Miguel A. Chávez-Fumagalli, Paula S. Lage, Vivian T. Martins, Lourena E. Costa, Tatiana G. Ribeiro, Wiliam C. B. Régis, Manuel Soto, Ana Paula Fernandes, Carlos A. P. Tavares & Eduardo A. F. Coelho. (2012) Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis. Parasitology Research 111:4, pages 1807-1816.
Crossref
Crossref
Alexandra K Marr, Bradford S McGwire & W Robert McMaster. (2012) Modes of action of Leishmanicidal antimicrobial peptides. Future Microbiology 7:9, pages 1047-1059.
Crossref
Crossref
Sonali Gangwar, Mirza S. Baig, Priyanka Shah, Subhashish Biswas, Sanjay Batra, Mohammad I. Siddiqi & Neena Goyal. (2012) Identification of Novel Inhibitors of Dipeptidylcarboxypeptidase of Leishmania donovani via Ligand-Based Virtual Screening and Biological Evaluation. Chemical Biology & Drug Design 79:2, pages 149-156.
Crossref
Crossref
Jason L. Weirather, Selma M. B. Jeronimo, Shalini Gautam, Shyam Sundar, Mitchell Kang, Melissa A. Kurtz, Rashidul Haque, Albert Schriefer, Sinésio Talhari, Edgar M. Carvalho, John E. Donelson & Mary E. Wilson. (2011) Serial Quantitative PCR Assay for Detection, Species Discrimination, and Quantification of Leishmania spp. in Human Samples. Journal of Clinical Microbiology 49:11, pages 3892-3904.
Crossref
Crossref
Tomas von Geldern, Michael Oscar Harhay, Ivan Scandale & Robert Don. 2011. Third World Diseases. Third World Diseases
181
241
.
Marta Gontijo Aguiar, Aline Márcia Machado Pereira, Ana Paula Fernandes & Lucas Antonio Miranda Ferreira. (2010)
Reductions in Skin and Systemic Parasite Burdens as a Combined Effect of Topical Paromomycin and Oral Miltefosine Treatment of Mice Experimentally Infected with
Leishmania
(
Leishmania
)
amazonensis
. Antimicrobial Agents and Chemotherapy 54:11, pages 4699-4704.
Crossref
Crossref
Donald J. AbrahamPatrick M. Woster. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
563
600
.
María Salomé Gachet, Javier Salazar Lecaro, Marcel Kaiser, Reto Brun, Hugo Navarrete, Ricardo A. Muñoz, Rudolf Bauer & Wolfgang Schühly. (2010) Assessment of anti-protozoal activity of plants traditionally used in Ecuador in the treatment of leishmaniasis. Journal of Ethnopharmacology 128:1, pages 184-197.
Crossref
Crossref
M. G. Aguiar, D. L. Silva, F. A. Nunan, E. A. Nunan, A. P. Fernandes & L. A. M. Ferreira. (2009) Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens. Journal of Antimicrobial Chemotherapy 64:6, pages 1234-1240.
Crossref
Crossref
Marieke VermeerschRaquel Inocêncio da LuzKim TotéJean-Pierre Timmermans, Paul CosLouis Maes. (2009)
In Vitro Susceptibilities of
Leishmania donovani
Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
. Antimicrobial Agents and Chemotherapy 53:9, pages 3855-3859.
Crossref
Crossref
I. Hachicha, M. Sellami, H. Fourati, R. Akrout, N. Hdiji & S. Baklouti. (2009) Leishmaniose cutanée au cours de la polyarthrite rhumatoïde. La Revue de Médecine Interne 30:7, pages 609-612.
Crossref
Crossref
Dae Hyun Kim, Hye Jin Chung, Joachim Bleys & Reza F. Ghohestani. (2009) Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials. PLoS Neglected Tropical Diseases 3:2, pages e381.
Crossref
Crossref
Rosario Diaz-González, Yolanda Pérez-Pertejo, Yves Pommier, Rafael Balaña-Fouce & Rosa M. Reguera. (2008) Mutational study of the “catalytic tetrad” of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance. Biochemical Pharmacology 76:5, pages 608-619.
Crossref
Crossref
Theodora Calogeropoulou, Panagiotis Angelou, Anastasia Detsi, Irene Fragiadaki & Effie Scoulica. (2008) Design and Synthesis of Potent Antileishmanial Cycloalkylidene-Substituted Ether Phospholipid Derivatives. Journal of Medicinal Chemistry 51:4, pages 897-908.
Crossref
Crossref
Gijsbert B. van der Voet & J.A. Centeno. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
262
272
.
Eduardo Ortega-Barria & Luz I. Romero. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
1246
1253
.
Samuel Vidal Mussi, Ana Paula Fernandes & Lucas Antonio Miranda Ferreira. (2007) Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis. Parasitology Research 100:6, pages 1221-1226.
Crossref
Crossref
Vinay Choubey, Pallab Maity, Mithu Guha, Sanjay Kumar, Kumkum Srivastava, Sunil Kumar Puri & Uday Bandyopadhyay. (2007)
Inhibition of
Plasmodium falciparum
Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism
. Antimicrobial Agents and Chemotherapy 51:2, pages 696-706.
Crossref
Crossref
P.M. Woster. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
815
843
.
Babu L Tekwani & Larry A Walker. (2006) 8-Aminoquinolines: future role as antiprotozoal drugs. Current Opinion in Infectious Diseases 19:6, pages 623-631.
Crossref
Crossref
I. Marie, C. Fevre, L. Favennec, P. Courville, J. Bernet & H. Levesque. (2006) Leishmaniose cutanée au cours d'une polymyosite. La Revue de Médecine Interne 27:7, pages 566-568.
Crossref
Crossref